News Headline Summary

Oncothyreon (ONTY) downgraded to neutral from outperform at Wedbush

Reaction details (18:24)

- Co's shares unreactive to the news, last trade at USD 2.01 (-55.33%), the large move on the day is due to earlier news that one of Co's experimental lung cancer drug missed its main goal in a study.

19 Dec 2012 - 18:21 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: